Drug Name |
Loxapine |
Drug ID |
BADD_D01326 |
Description |
An antipsychotic agent used in schizophrenia. [PubChem] |
Indications and Usage |
For the management of the manifestations of psychotic disorders such as schizophrenia |
Marketing Status |
approved |
ATC Code |
N05AH01 |
DrugBank ID |
DB00408
|
KEGG ID |
D02340
|
MeSH ID |
D008152
|
PubChem ID |
3964
|
TTD Drug ID |
D0U5OE
|
NDC Product Code |
51097-001; 0527-1395; 50090-4701; 70518-0347; 0591-0369; 35573-436; 35573-438; 35573-439; 70518-1792; 0591-0370; 62135-492; 64850-892; 0591-0372; 0591-0371; 0527-1397; 70518-0416; 64850-890; 0527-1394; 0527-1396; 53296-0095; 62135-493; 70518-1681; 64850-891; 64850-893; 70518-0346; 70518-1896; 35573-437 |
UNII |
LER583670J
|
Synonyms |
Loxapine | 2-Chloro-11-(4-methyl-1-piperazinyl)-dibenz(b,f)(1,4)oxazepine | Oxilapine | Cloxazepine | Loxapine Hydrochloride | Hydrochloride, Loxapine | Loxitane | Loxapine Succinate | Succinate, Loxapine | Loxapinsuccinate | Loxipine Succinate | Loxipine Maleate | Maleate, Loxipine | CL-71,563 | CL 71,563 | CL71,563 | Loxapine Monohydrochloride |